| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 48.809 | 48.035 | 60.034 | 58.322 | 57.995 | 50.270 | 35.320 | 40.409 | 39.736 |
| Total Income - EUR | 0 | 48.809 | 48.035 | 60.054 | 58.349 | 58.174 | 50.169 | 41.075 | 45.521 | 39.749 |
| Total Expenses - EUR | 1 | 39.099 | 47.287 | 43.378 | 49.213 | 39.270 | 32.569 | 30.363 | 33.968 | 30.400 |
| Gross Profit/Loss - EUR | -1 | 9.710 | 748 | 16.675 | 9.136 | 18.905 | 17.599 | 10.712 | 11.552 | 9.348 |
| Net Profit/Loss - EUR | -1 | 9.222 | 268 | 16.075 | 8.553 | 18.342 | 17.062 | 10.365 | 11.207 | 9.020 |
| Employees | 0 | 4 | 4 | 5 | 4 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Impressmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 117 | 8.907 | 7.663 | 10.454 | 10.252 | 6.587 | 3.996 | 2.331 | 2.729 | 1.238 |
| Current Assets | 960 | 11.172 | 3.596 | 19.398 | 12.423 | 29.379 | 50.497 | 26.589 | 11.632 | 12.947 |
| Inventories | 860 | 4.530 | 1.846 | 137 | 2.797 | 1.447 | 625 | 1.438 | 1.343 | 1.687 |
| Receivables | 0 | 0 | 2 | 1.488 | 0 | 0 | 5.415 | 6.510 | 301 | 0 |
| Cash | 100 | 6.642 | 1.749 | 17.773 | 9.626 | 27.932 | 44.457 | 18.641 | 9.988 | 11.260 |
| Shareholders Funds | 44 | 9.266 | 9.376 | 25.279 | 16.653 | 34.679 | 50.971 | 20.939 | 11.462 | 10.718 |
| Social Capital | 45 | 45 | 44 | 43 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 1.033 | 10.814 | 1.889 | 4.575 | 6.115 | 1.438 | 2.011 | 4.395 | 2.943 | 3.659 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 5.415 | 5.127 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1423 - 1423" | |||||||||
| CAEN Financial Year |
1412
|
|||||||||
Comments - Impressmed Srl